A Dollar-Store Vitamin, Promoted to Anxiety Cure
The post went around the way these always do. A real drug name, a real study citation, and a row of numbers that look like a clinical trial pulled off a heist: vitamin B1, 200 milligrams a day, cut PMS anxiety by 96%, depression by 80.4%, sleep problems by 80%, and fatigue by 74%. Nearly a thousand likes, several hundred bookmarks, sixty-thousand impressions. The framing was the familiar one — a cheap vitamin your doctor never mentions, hiding in plain sight in the medical literature.1
I want to be precise about what's true here, because the deception in this case is unusually elegant. Those numbers are not invented. They appear, verbatim, in a peer-reviewed paper. A reader can click through, find the PMID, and see "anxiety (96%)" printed in the results. That's what makes the claim sticky. It survives the first round of fact-checking that kills most wellness hype.
It does not survive the second. Because the numbers are real, and they are also not what the study found. They are the single best-performing items cherry-picked out of a twenty-symptom checklist, presented as if they were the headline. The study's actual headline — the number a careful reader is supposed to walk away with — was a 35% reduction in psychological symptoms and a 21% reduction in physical ones.2 Real, modest, and roughly a third of what the post advertised for anxiety alone.
This is the topic for today: how one small trial of eighty women in an Iranian dormitory became a viral promise about a vitamin you can buy for the price of a coffee, and what the evidence on thiamine for premenstrual syndrome actually supports. Spoiler, since I don't believe in burying the verdict: it's safe, it's cheap, and the case for it rests on a single unreplicated study that the internet has inflated by roughly threefold.
The numbers are real. They are also not what the study found.
Dr. Maren ColeWhat Thiamine Actually Does, and Why That Isn't the Same as Treating PMS
Thiamine — vitamin B1 — is not a fringe compound. It's one of the eight B vitamins, an essential micronutrient your body cannot make and must get from food. In its active form, thiamine pyrophosphate, it's a coenzyme for several of the workhorse reactions of energy metabolism: pyruvate dehydrogenase, transketolase, alpha-ketoglutarate dehydrogenase. Translated out of biochemistry, it helps convert the carbohydrates you eat into usable cellular energy, and it supports normal nerve function and the synthesis of neurotransmitters like acetylcholine.3
Genuine thiamine deficiency is a serious thing. It causes beriberi and, in the context of chronic alcohol use, Wernicke-Korsakoff syndrome — conditions involving the heart and the nervous system. The symptoms of deficiency include fatigue, irritability, and difficulty concentrating, which is where the PMS story starts to get its plausibility. Fatigue and mood disturbance overlap with what people feel premenstrually, so the logical leap is easy to make: if low thiamine causes fatigue and mood symptoms, more thiamine should fix them.
Here is where the logic quietly breaks. The women in the viral study were not thiamine-deficient. They were ordinary university students eating ordinary diets. Correcting a deficiency that doesn't exist is not how supplements work. And the proposed mechanism — that megadose thiamine boosts energy metabolism and serotonergic tone enough to blunt a luteal-phase mood disorder — is what I'd call biologically plausible but entirely non-specific. It's the mechanism by which thiamine matters for everyone's basic physiology. It does not explain why flooding a well-nourished body with 180 times its daily requirement would specifically target premenstrual anxiety.
There's a second problem, and it's physical. Thiamine is water-soluble, and the gut's capacity to absorb it is limited. Above roughly 5 milligrams in a single dose, absorption efficiency falls off sharply, and whatever your kidneys don't need gets excreted in urine.4 So the dramatic framing — "200 milligrams!" — runs into a ceiling. You cannot get 180 times the physiological effect out of 180 times the dose, because your body simply won't take most of it up. A meaningful fraction of that megadose is, to put it bluntly, expensive urine.
One Trial of Eighty Women, Versus Everything Else
Let's go to the actual paper, because it deserves a fair reading rather than a dunk. It's a real randomized controlled trial, and on its own terms it's not a bad one.
Design. Double-blind, placebo-controlled, parallel-group trial in female university students in Jahrom, Iran, with mild-to-moderate PMS. 100 randomized, 80 completed and analyzed (40 B1, 40 placebo). Dose: 200 mg/day of thiamine, taken only in the week before menstruation, across three cycles.2
Results: Psychological symptoms fell 35.1% in the B1 group; physical symptoms fell 21.2%; overall severity fell 32.1% versus 12% on placebo. B1 beat placebo on every measure, with high statistical significance. Within the symptom-by-symptom breakdown, the largest single reductions were anxiety (96%), depression (80.4%), and sleep disturbance (80.2%) — the numbers the viral post used.
Limitation: One single-center study in one narrow population (single, non-exercising women 18–30 in one country), never independently replicated, published in a low-impact author-pays journal. Several reported standard deviations are implausibly small, and the abstract and methods disagree on the treatment duration — anomalies that lower confidence in the precision of every number.
Read that limitation line twice, because it's the whole story. This is not a fraudulent study and I'm not calling it one. But it is a single, small, single-population trial, and in the decade since its publication, no independent group in any other country or lab has reproduced it.2 In evidence terms, an unreplicated result is a hypothesis with good manners. It is not a settled fact.
The contrast that matters is with the B vitamin that actually does have a track record for PMS: B6, pyridoxine. A 1999 systematic review in the BMJ pooled nine randomized trials covering 940 women and found B6 roughly doubled the odds of symptom improvement.5 That's a far stronger evidence base than B1 has — and even there, the authors flagged that most of the studies were poor quality and showed no dose-response. So the better-studied B vitamin earns only a cautious "probably helps." The viral claim takes the less-studied vitamin and assigns it the more dramatic numbers. That inversion should set off alarms.
Vitamin B6 for PMS. Nine RCTs pooled; odds ratio for overall symptom improvement around 2.3, and 2.1 for depressive symptoms, favoring B6 over placebo.5
Limitation: Authors explicitly judged most included trials low quality with no dose-response signal. This is the well-studied B vitamin for PMS, and it still only clears a weak "probably."
A 2024 systematic review in Nutrition Reviews looked across the whole nutritional-intervention literature for PMS mood symptoms. It cited the thiamine trial honestly — reporting the 35% figure, not 96% — and concluded that the most consistent evidence was for vitamin B6, calcium, and zinc, with thiamine resting on that lone study.6 An older systematic review reached the same hierarchy, with calcium at around 1,200 mg/day as the best-supported supplement for PMS.7 In none of these reviews does high-dose B1 emerge as a front-line answer.
And then there's the most quietly devastating data point. A nested analysis within the Nurses' Health Study II — over a thousand PMS cases — found that thiamine and riboflavin from food were associated with a lower risk of developing PMS. Thiamine from supplements showed no such association.8 The population evidence, in other words, points toward dietary B vitamins and specifically did not find a benefit from the pills.
Dietary vs. supplemental B vitamins. In the Nurses' Health Study II, higher intake of thiamine and riboflavin from food sources was linked to a roughly 25–35% lower risk of developing PMS. Intake from supplements showed no protective association.8
Limitation: Observational, so it shows association, not causation, and it measures PMS onset rather than treatment. But the food-versus-pill split is the opposite of what the supplement narrative predicts.
The placebo group still improved 12% overall — a reminder that PMS carries a large placebo response.2,4
How a Footnote Became a Headline
It's worth dissecting exactly how the viral number was built, because the technique recurs constantly and recognizing it is a transferable skill. The trial measured twenty PMS symptoms, each scored on a small zero-to-three scale. When the authors listed the per-symptom changes, anxiety happened to show the largest drop, at 96%. Right alongside it in the same sentence sat the symptoms that barely moved: headache fell 8%, breast tenderness 7%, palpitations under 4%, and decreased libido under 1%.2
The viral post quoted the top four and silently dropped the rest. That's selection, not summary. It's the difference between "our best student scored 96 on the final" and "the class average was 35."
Three more distortions stack on top. First, the 96% is a within-group, before-versus-after change — not the benefit over placebo, and the placebo group improved 12% on its own. Second, big percentages off tiny absolute scores are deceptive: a symptom score dropping from near one to near zero reads as a huge percentage but reflects a fraction of a point on a self-report diary. Third, the dosing was luteal-phase only — one week a month — while the post implies you simply take it daily, forever, like a daily multivitamin.
It's the difference between "our best student scored 96" and "the class average was 35."
On reading the same data two waysCherry-picked sub-symptom
96% was the single best-moving item on a 20-symptom list. The honest summary statistic was a 35% drop in psychological symptoms.
Within-group, not vs. placebo
The big numbers are before-versus-after inside the treatment arm. Placebo alone produced a 12% overall improvement.
One population, never replicated
80 single Iranian students, 18–30, non-exercising. No reproduction in any other group or country in ten years.
Absorption ceiling
Above ~5 mg per dose, thiamine uptake falls off and the excess is excreted. A 200 mg dose can't deliver 180× the effect.
The One Honest Leg the Claim Stands On
Here's where I'll give the hype its due, because fairness is the entire point of this newsletter. High-dose oral thiamine is genuinely low-risk. It's water-soluble, the body excretes what it can't use, and the U.S. Food and Nutrition Board has set no Tolerable Upper Intake Level for it, citing a lack of reported adverse effects from high intakes.4 Doses in the hundreds of milligrams are used in clinical practice without toxicity. At 200 mg a day, the safety case is solid.
One caveat worth stating clearly, because it gets conflated: the rare reports of anaphylaxis from thiamine involve intravenous administration, not oral tablets. Swallowing a B1 pill is not the same as receiving an injection, and the oral route is well tolerated.3
But "safe" and "effective" are different claims, and the supplement narrative leans hard on the first to imply the second. Thiamine is sold as a dietary supplement, not an FDA-approved treatment for PMS — there is no approved drug indication here, and marketers can only use structure-function language like "supports mood balance."4 Meanwhile the clinical guidelines that do address PMS — from bodies like the American College of Obstetricians and Gynecologists — recommend calcium at around 1,200 mg/day, B6 capped near 100 mg, magnesium, lifestyle measures, and SSRIs for severe cases.9 High-dose B1 appears in none of them. The cheapness that makes it attractive is real; the "your doctor is hiding this" framing is not. Your doctor isn't recommending it because the evidence is one study.
Dr. Cole's Read
This is a textbook case of a real but thin signal stretched into a universal promise. There is one randomized trial. It's small, single-center, single-country, never replicated, and reported with a few statistical quirks that warrant caution. On its own terms it found a modest, genuine effect — about a third reduction in psychological PMS symptoms — that beat placebo. That is interesting. It is a reason to fund a larger, multi-site replication. It is not a reason to claim a 96% cure.
I'm rating this Insufficient Data, not Marketing Hype, and the distinction matters. There's a real clinical signal underneath the distortion and the compound is cheap and safe, so this isn't pseudoscience. But "one unreplicated trial, overstated by roughly threefold" is the definition of insufficient data, not promising — promising would require convergent or reproduced evidence, and that doesn't exist yet.
If you're managing PMS and want a supplement with actual guideline support, calcium and B6 have far more behind them than thiamine does. And if you want to try high-dose B1 anyway, the honest pitch is: it's unlikely to hurt you, it's inexpensive, and it might do something modest — not that it will cut your anxiety by 96%.
One 80-woman study found a real 35% dip in PMS mood symptoms. The viral "96%" is a cherry-picked footnote from that same paper. B1 is cheap and safe — but the evidence is a single unreplicated trial, and calcium and B6 have more behind them.
- 1. Viral social-media claim (X, May 2026) asserting 200 mg/day vitamin B1 reduced PMS anxiety 96%, depression 80.4%, sleep disturbance 80%, and fatigue 74%. The figures trace directly to Abdollahifard et al. 2014 (ref. 2).
- 2. Abdollahifard S, Rahmanian Koshkaki A, Moazamiyanfar R. The Effects of Vitamin B1 on Ameliorating the Premenstrual Syndrome Symptoms. Global Journal of Health Science. 2014;6(6):144–153. PMID: 25363099. Double-blind RCT, 200 mg/day luteal-phase thiamine, 80 analyzed; psychological symptoms −35.1%, physical −21.2%; max single-symptom reductions: anxiety 96%, depression 80.4%, sleep 80.2%.
- 3. Vitamin B1 (Thiamine). StatPearls, NCBI Bookshelf (NBK482360). Biochemistry of thiamine pyrophosphate, coenzyme roles, deficiency states; oral vs. intravenous safety distinction.
- 4. National Institutes of Health, Office of Dietary Supplements. Thiamin — Health Professional Fact Sheet. RDA 1.1 mg/day (women); no Tolerable Upper Intake Level established; absorption declines above ~5 mg per dose; excess excreted.
- 5. Wyatt KM, Dimmock PW, Jones PW, O'Brien PMS. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318(7195):1375–1381. Nine RCTs, 940 women; OR ~2.3 overall improvement, 2.1 depressive symptoms; authors flag poor study quality and no dose-response.
- 6. Robinson J, Ferreira A, Iacovou M, Kellow NJ. Effect of nutritional interventions on the psychological symptoms of premenstrual syndrome: a systematic review of RCTs. Nutrition Reviews. 2025;83(2):280–306. PMID: 38684926. Reports the B1 trial's honest 35% figure; identifies B6, calcium, and zinc as most consistent.
- 7. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16(3):e407–e429. PMID: 19923637. Calcium best-supported; B6 and magnesium mixed; thiamine not a focus.
- 8. Chocano-Bedoya PO, Manson JE, Hankinson SE, et al. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr. 2011;93(5):1080–1086. PMID: 21346091. Thiamine and riboflavin from food inversely associated with PMS risk; no association for supplemental intake.
- 9. American College of Obstetricians and Gynecologists. Premenstrual Syndrome (PMS) patient FAQ; and MSD Manual (Professional), Premenstrual Syndrome. Recommend calcium ~1,200 mg/day, B6 ≤100 mg/day, magnesium, lifestyle measures, SSRIs for severe PMS/PMDD; no high-dose B1 recommendation.
- 10. Agha M, Zafari M. Comparison of the effect of vitamin B1 and ibuprofen on primary dysmenorrhea. Journal of Women's Health (Iran). 2009. B1 comparable to ibuprofen for menstrual cramps — a different condition from PMS; cited as supporting context only, not independently verified.